West Chester Capital Advisors, Inc Bristol Myers Squibb CO Transaction History

West Chester Capital Advisors, Inc

$52.2 Million
Q3 2023

A detailed history of West Chester Capital Advisors, Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, West Chester Capital Advisors, Inc holds 6,035 shares of BMY stock, worth $350,030. This represents 0.67% of its overall portfolio holdings.

Number of Shares

6,035

Previous 6,475 6.8%

Holding current value

$350,030

Previous $414,000 15.46%

% of portfolio

0.67%

Previous 0.81%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$57.89 - $64.73 $25,471 - $28,481	-440 Reduced 6.8%	6,035 $350,000
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $278,094 - $308,780	-4,365 Reduced 40.27%	6,475 $414,000
Q1 2023 May 04, 2023	SELL	$65.71 - $74.53 $4,928 - $5,589	-75 Reduced 0.69%	10,840 $751,000
Q4 2022 Feb 06, 2023	SELL	$68.48 - $81.09 $2,396 - $2,838	-35 Reduced 0.32%	10,915 $785,000
Q3 2022 Oct 31, 2022	SELL	$0.13 - $76.84 $3 - $1,997	-26 Reduced 0.24%	10,950 $778,000
Q2 2022 Jul 28, 2022	SELL	$72.62 - $79.98 $93,171 - $102,614	-1,283 Reduced 10.47%	10,976 $845,000
Q1 2022 May 03, 2022	BUY	$61.48 - $73.72 $62,340 - $74,752	1,014 Added 9.02%	12,259 $895,000
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $58,349 - $68,021	-1,088 Reduced 8.82%	11,245 $701,000
Q3 2021 Nov 05, 2021	SELL	$59.17 - $69.31 $26,034 - $30,496	-440 Reduced 3.44%	12,333 $730,000
Q2 2021 Jul 15, 2021	SELL	$61.91 - $67.42 $111,376 - $121,288	-1,799 Reduced 12.35%	12,773 $853,000
Q1 2021 May 04, 2021	SELL	$59.34 - $66.74 $112,983 - $127,072	-1,904 Reduced 11.56%	14,572 $920,000
Q4 2020 Feb 03, 2021	BUY	$57.74 - $65.43 $69,634 - $78,908	1,206 Added 7.9%	16,476 $1.02 Million
Q3 2019 Nov 08, 2019	BUY	$42.77 - $50.71 $4,277 - $5,071	100 Added 0.66%	15,270 $774,000
Q2 2019 Jul 30, 2019	BUY	$44.62 - $49.34 $38,774 - $42,876	869 Added 6.08%	15,170 $688,000
Q1 2019 Apr 24, 2019	SELL	$45.12 - $53.8 $13,761 - $16,409	-305 Reduced 2.09%	14,301 $682,000
Q4 2018 Feb 07, 2019	BUY	$48.76 - $63.23 $8,240 - $10,685	169 Added 1.17%	14,606 $759,000
Q3 2018 Oct 29, 2018	SELL	$55.19 - $62.25 $27,815 - $31,374	-504 Reduced 3.37%	14,437 $897,000
Q2 2018 Jul 25, 2018	SELL	$50.53 - $62.98 $33,602 - $41,881	-665 Reduced 4.26%	14,941 $827,000
Q1 2018 May 04, 2018	BUY	$59.92 - $68.98 $14,680 - $16,900	245 Added 1.59%	15,606 $984,000
Q4 2017 Feb 12, 2018	BUY	$59.94 - $65.35 $920,738 - $1 Million	15,361	15,361 $971,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of West Chester Capital Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on West Chester Capital Advisors, Inc with notifications on news.

Account

West Chester Capital Advisors, Inc Bristol Myers Squibb CO Transaction History